Hold BHEL, says Sudarshan Sukhani

Published on Fri, Feb 17, 2012 at 12:10 |  Source : CNBC-TV18

Updated at Fri, Feb 17, 2012 at 12:14  

82996 Investors following BHEL. Share this News with them.
0
0
Share on Tumblr
Sudarshan Sukhani ,  s2analytics.com

Excerpts from Markets Midday on CNBC-TV18 Watch the full show ยป

ALSO READ

Hold BHEL , says Sudarshan Sukhani of s2analytics.com.

Sukhani told CNBC-TV18, "I would recommend booking profits in power stocks. The fresh buying should be done only when the markets cool off, at least these stocks cool off a little."

He further added, "In BHEL you could see significant upside. I would suggest holding it. My suggestion was that BHEL will be an outperformer and as a matter of co-incidence it started the process today itself. So this is probably not the end of the rally for BHEL, its just starting its bull market. Don't be in a hurry, even after three months also do not be in a hurry to exit. You have lashed down to one of the best stocks in this on going bull market."

"My recommendation would be to take profits in Thomas Cook . We have seen Thomas Cook run up at the current levels of Rs 65. There is significant resistance and price action does not suggest that this resistance will be overcome easily. This is a bull market, so you can hold onto any stock and you will make money hopefully. But you might like to switch from Thomas Cook to something like ICICI Bank or BHEL or even Infosys . Thomas Cook has some limitations."

  

Trending News

Business News

2TB drives offer best value for money
Did Sebi miss any tricks in Ambani consent order? "Did Sebi miss any tricks in Ambani consent order?"

Oppn gears up to make Bharat bandh a success

On Facebook IPO Morgan Stanley Speculation Of 'Nefarious Activity' Around IPO Untrue

The latest earning numbers FIRST on CNBC-TV18
Videos

May 30 2012, 23:16

Clash of Spain and ECB worrying investors: Verstrate

- in FII View

May 30 2012, 11:18

Result corner: Ajay Bodke`s top bets from across sectors

- in MARKET OUTLOOK

Interviews

May 30 2012, 17:04 | Source: CNBC-TV18

Margins may be hit on one-off items in EBITDA: Sun Pharma  

May 30 2012, 16:32 | Source: CNBC-TV18

Essar announces Rs 175cr deal; to pay-off debts with fund  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!